Results 11 to 20 of about 27,510 (305)
Cutaneous polyarteritis nodosa [PDF]
British Journal of Dermatology, 2002 Classic polyarteritis nodosa (PAN) is a segmentary leucocytoclastic vasculitis that affects small- and medium-sized arteries. In 1931, Lindberg (Acta Med Scand 1931; 76: 183-225) described the existence of a cutaneous variant of PAN, without visceral involvement and with a more favourable prognosis. We present four patients diagnosed with cutaneous PAN
España, A. (Agustín) +2 more
openaire +5 more sources
Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare [PDF]
Case Reports in Medicine, 2009 Polyarteritis nodosa (PAN) is a systemic vasculitis whose severe forms are treated with glucocorticoids and cyclophosphamide. Refractory patients are exposed to many complications, notably accelerated atherosclerosis.
Emmanuel Ribeiro +7 more
doaj +3 more sources
Myocarditis and intramural coronary vasculitis in polyarteritis nodosa: an unusual treatable form of heart failure [PDF]
ESC Heart Failure, 2020 We describe an uncommon cardiac presentation of polyarteritis nodosa. A 68‐year‐old woman, with a history of fatigue, weight loss, and myalgia of the lower extremities, was admitted for congestive heart failure.
Cristina Chimenti +7 more
doaj +2 more sources
Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature [PDF]
Diagnostic Pathology, 2012 Angioimmunoblastic T-cell lymphoma is one of the most common subtypes of peripheral T-cell lymphoma (15-20% of all cases), accounting for approximately 1-2% of all non-Hodgkin lymphomas.
Ambrosio Maria +7 more
doaj +4 more sources
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa [PDF]
Pediatric Rheumatology Online Journal, 2015 Objectives Definitive sample sizes for clinical trials in rare diseases are usually infeasible. Bayesian methodology can be used to maximise what is learnt from clinical trials in these circumstances.
Lisa V. Hampson +21 more
semanticscholar +3 more sources
Polyarteritis Nodosa with Bilateral Asynchronous Testicular Necrosis: A Case Report [PDF]
Case Reports in Urology, 2011 Polyarteritis nodosa (PAN) is a systemic vasculitis which may result in thrombosis or aneurysm formation in any organ of the body. We report a case polyarteritis nodosa (PAN) resulting in bilateral asynchronous testicular necrosis.
Nicholas J. Toepfer +3 more
doaj +4 more sources
Arthritis & Rheumatology, 2021 To provide evidence‐based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN).
Sharon A. Chung +31 more
semanticscholar +2 more sources
Modern Rheumatology Case Reports, 2022 The global outbreak of coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 has prompted the rapid spread and development of vaccines to prevent the spread of the disease.
Y. Ohkubo +3 more
semanticscholar +1 more source
Techniques in Vascular and Interventional Radiology, 2014 The first description of polyarteritis nodosa (PAN) was in 1852 by Karl Rokitansky, a pathologist at the University of Vienna. The initial report describes a 23-year-old man who had a 5-day history of fever and diarrhea. Since then, the definition of PAN has evolved.
Howard, Travis +3 more
openaire +2 more sources
Arthritis & Rheumatology, 2021 Cyclophosphamide (CYC) is used in clinical practice off‐label for the induction of remission in childhood polyarteritis nodosa (PAN). Mycophenolate mofetil (MMF) might offer a less toxic alternative.
P. Brogan +22 more
semanticscholar +1 more source